Merit Financial Group’s GSK GSK Stock Holding History

Merit Financial Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.05M	Buy	39,159 +1,430	+4%	+$75.6K	0.01%	742
2026 Q1	$2.08M	Buy	37,729 +4,656	+14%	+$252K	0.02%	665
2025 Q4	$1.62M	Sell	33,073 -2,982	-8%	-$139K	0.01%	724
2025 Q3	$1.56M	Buy	36,055 +4,342	+14%	+$170K	0.01%	669
2025 Q2	$1.22M	Buy	31,713 +10,938	+53%	+$418K	0.01%	699
2025 Q1	$805K	Buy	+20,775	New	+$761K	0.01%	736
2024 Q2	–	Sell	-5,302	Closed	-$231K	–	926
2024 Q1	$231K	Buy	+5,302	New	+$219K	0.01%	783
2022 Q3	–	Sell	-6,610	Closed	-$360K	–	602
2022 Q2	$360K	Buy	6,610 +2,248	+52%	+$124K	0.01%	414
2022 Q1	$238K	Buy	+4,362	New	+$237K	0.01%	337

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Merit Financial Group's GSK Position: Q2 2026 in Review

Merit Financial Group increased its GSK (GSK) stake by 3.8% in Q2 2026, buying an estimated $75.6K and bringing the position to 39,159 shares worth $2.05M. The position accounts for 0.01% of the portfolio, ranked #742.

Merit Financial Group first reported a position in GSK in Q1 2022 and has held it in 9 quarters since. The position peaked at $2.08M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Merit Financial Group held 39,159 shares of GSK worth $2.05M as of Q2 2026.
Merit Financial Group bought 1,430 GSK shares in Q2 2026, an estimated $75.6K.
GSK made up 0.01% of Merit Financial Group's portfolio in Q2 2026, its #742 holding.
Merit Financial Group first reported a position in GSK in Q1 2022 and has held it in 9 quarters since.
Merit Financial Group's GSK position peaked at $2.08M in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.